Nirrin Technologies

Biotechnology
$20Mtotal raised · 4 rounds on record
$6.7Mlatest round · Venture round · Sep 2025 · 13 mo ago
$2.1Mgrants · 1 grant · CORDIS
50+team · employees, estimated range

Overview

New product announcement — protein measurement made simple. Meet TALOS About Nirrin Built to work in the real world Nirrin builds high-performance optical instruments and analytics that help bioprocess teams generate trustworthy data in real workflows — from development through manufacturing.

Funding and backers

Total raised
$20M
4 rounds on record
Latest round
$6.7M
Venture round · Sep 2025 · 13 mo ago
Team
51-200
employees, estimated range
Grants
$2.1M
1 grant · CORDIS
The money's age
Due for its next round
13 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 3 Launched Nirrin Technologies Launches TALOS, a Protein Quantitation System Designed for Modern Biopharmaceutical Manufacturing Workflows · YahooFinance Sep 23, 2025 Raised a round Venture round $6.7M · SEC Form D Sep 3, 2024 Won a grant $2.1M · CORDIS Feb 14, 2024 New executive Gregory Cresenzi, Executive Officer · SEC Form D Feb 1, 2024 Raised a round Venture round $4.8M · SEC Form D Oct 20, 2021 Board appointment John Ho, Director · SEC Form D Oct 6, 2021 Raised a round Venture round $8.5M · SEC Form D 2017 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Sep 2025 $6.7M — SEC Form D
Grant Sep 2024 $2.1M — CORDIS
Venture round Feb 2024 $4.8M — SEC Form D
Venture round Oct 2021 $8.5M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Nirrin Technologies, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Bryan HassellExecutive OfficerSEC Form D
David SeldinDirectorSEC Form D
Debrah HermanExecutive OfficerSEC Form D
Jonathan HartmannExecutive Officer, DirectorSEC Form D
Gregory CresenziExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs Invert, Upsolve AI
Lightspeed Venture Partners
backs SphinxML Inc.
Techstars
backs Qurate
Soma Capital
backs Upsolve AI
Partech
backs CO2 AI
Point72 Ventures
backs SphinxML Inc.
Similar startupsby what they do, their industry and backers
Upsolve AIFounded 2023 · 11-50 employees · 1 role
Upsolve AI: the platform to build, deploy, and evaluate grounded, governed, trustworthy data agents. Agent Context Studio is the context…
InvertVenture round $20.1M · 2 yr ago · Founded 2021 · 11-50 employees · 4 roles
Infrastructure and intelligence for bioprocess — for development and manufacturing teams at biopharma, synthetic biology, and CDMOs.
DataHowSeries A · 2 mo ago · 51-200 employees
Discover AI-powered bioprocess development. Enhance efficiency, maximize outcomes, and transform your bioprocess operations with innovative…
Qurate
Loading... We will be making an announcement soon.
CO2 AIFounded 2023 · 11-50 employees · 1 role
Engage your teams, suppliers, and stakeholders to build business success on real carbon reduction. CO2 AI delivers trustworthy data, custom…
FrendyVenture round $240k · 2 yr ago
Frendy on IT-talo, joka tarjoaa jatkuvat palvelut sekä erilaiset kehittämishankkeet moderniin IT-arkeen ja tietotyöhön.

Financials

Total raised
$22.2M
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $6.7M Details
Grant 2024 $2.1M Details
Venture - Series Unknown 2024 $4.8M Details
Venture - Series Unknown 2021 $8.5M Details

People

Bryan Hassell
Executive Officer
SEC Form D
David Seldin
Director
SEC Form D
Debrah Herman
Executive Officer
SEC Form D
Jonathan Hartmann
Executive Officer, Director
SEC Form D
Gregory Cresenzi
Executive Officer
SEC Form D
David Michael
Director
SEC Form D
Matthew Gunnison
Director
SEC Form D
John Ho
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

News

News YahooFinance 2 months ago
Nirrin Technologies Showcases Next-Generation Bioprocess Analytical Platform and Workflows at BPI Conference and Exhibition
BILLERICA, Mass., September 15, 2026--Nirrin Technologies, a developer of analytical tools designed to transform bioprocessing workflows, will showcase its Tunable Laser Near-Infrared (TL-NIR) platform at the BPI Conference & Exhibition, September 22-25 i
Read more
Report
News PRNewswire 5 months ago
PRN_FinancialWrapper
PRN_FinancialWrapper
Read more
Report
News morningstar.com 5 months ago
Nirrin Technologies and S.T. Japan Announce Exclusive Distribution Partnership for TALOS in Japan Read more
Report
News YahooFinance 5 months ago
Nirrin Technologies Launches TALOS, a Protein Quantitation System Designed for Modern Biopharmaceutical Manufacturing Workflows
BILLERICA, Mass., June 03, 2026--Nirrin Technologies, a developer of analytical tools designed to transform bioprocess workflows, today announced the commercial launch of TALOS, a direct protein quantitation system built on the company's proprietary High-
Read more
Report
News 01net.it 1 year ago
Nirrin Technologies Granted Patent for Cutting-Edge Flow-Cell Technology, Advancing Real-time Bioprocess Monitoring Read more
Report
Press release businesswire.com 1 year ago
Nirrin Technologies Establishes Scientific Advisory Board with Seasoned Leaders in Biomanufacturing and Advanced Therapeutic Development Read more
Report
Award streetinsider.com 2 years ago
NIH Awards Nirrin Technologies $2M SBIR Grant to Expand Development of HPTLS Technology Platform for Biomanufacturing Read more
Report

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Billerica United States
HQ
50-200 est. staff
44 Manning Rd., Billerica, MA 01821
company site